RPG Life Sciences has informed that a meeting of the board of directors of the company will be held on May 07, 2013, to consider and approve audited financial results for the year ended on March 31, 2013; and recommendation of dividend for the year 2012-13, if any.
The above information is a part of company’s filings submitted to BSE.